Effingham, IL-(Effingham Radio)- The Effingham County Health Department announces seventy-one new positive cases of Coronavirus Disease (COVID-19); when added to the numbers released on Monday, it brings our seven-day total to ninety-one (91), an increase of 16.6% from last week. With Thanksgiving less than 2 weeks away we ask the community to think about how they can reduce their risks if attending family gatherings.
Positive case demographics are as follows:
Monday, November 8, to
Thursday, November 11, 2021 |
||
Age | Male | Female |
< 1 | 2 | – |
< 10 | 4 | 2 |
Teens | 1 | 3 |
20’s | 5 | 6 |
30’s | 6 | 8 |
40’s | 4 | 4 |
50’s | 3 | 2 |
60’s | 10 | 4 |
70’s | 1 | 5 |
80’s | 1 | – |
90’s | – | – |
Illinois Region 6 rolling test positivity was 4.1% through November 9, with Effingham County at 6% for the same period.
This week our region saw a worrying increase in hospitalized COVID patients this is combined with an ICU bed availability rate that is now down to 14%. This is well below the warning level of 20%, and means that as we head into flu season and a possible new surge of COVID that the medical system in our region is strained.
Moderna and Pfizer Booster Clinics are now available to book online and can be booked at www.effcohealth.org (A reminder that a Booster Dose is different from a Third Dose. The Third Dose is only for the immunocompromised.)
Moderna and Pfizer booster shots will be for those who completed their initial series at least 6 months ago and are:
- 65 years and older
- Age 18+ who live in long-term care settings
- Age 18+ who have underlying medical conditions
- Age 18+ who work in high-risk settings
- Age 18+ who live in high-risk settings
For Janssen (Johnson and Johnson) COVID-19 vaccine, a single COVID-19 vaccine booster dose is recommended for persons aged 18 years and older, greater than or equal to 2 months after receipt of the initial Janssen dose.
The CDC shared that the clinical considerations for heterologous mixing (“mix and match”) are as follows:
- The same product that was used for the primary regimen should be used for the booster
- If that is not available or another product is preferred, heterologous boosting with a single dose of any of the authorized COVID-19 vaccine boosters is acceptable
- Heterologous dosing may be considered for the booster dose only
- Individual benefit-risk assessment may inform which booster product to use
As a community we know what to do and have all the resources to reduce the spread of COVID-19. Please:
- Vaccinate
- Distance socially
- Use masks,
- Practice hand hygiene,
- Socialize outdoors or in well ventilated locations,
- Avoid crowds
- Isolate and quarantine when required
Comments